ImmunoCAP Tryptase Test Unique Marker of Severe Reactions/Mastocytosis
本ページで紹介している製品は、日本では薬機法上未承認であり、国内での販売・提供は行っておりません。
最新の製品情報はグローバルサイトをご参照ください。
The products described on this page are not approved under the Japanese regulatory framework and are not available for sale or distribution in Japan.
Please refer to the global website for the latest product information.
ImmunoCAP™ Tryptase is a unique marker that measures the total level of tryptase released by mast cells into circulation. Elevated tryptase levels help clinicians confirm mast cell activation during a severe allergic reaction, to decide if venom immunotherapy (VIT) is appropriate and to support the diagnosis of mastocytosis.1-3 ImmunoCAP Tryptase enables the measurement of transient increases in the level of tryptase as well as the establishment of the person’s baseline tryptase level. A transient increase of tryptase during a severe reaction helps to identify and assess the extent of the reaction.1 A persistent elevated baseline level of tryptase is an indication of possible mastocytosis.1,3
ImmunoCAP Tryptase testing in addition to clinical findings can help healthcare providers make:
Accurate diagnosis
- Severe reaction: Tryptase testing and relevant, specific IgE antibody testing, help identify if the underlying cause of the severe reaction is an allergy.4,5
- Mastocytosis: Tryptase baseline levels reflect the mast cell burden in the body and can help to rule in or rule out systemic mastocytosis.1,3
Assessment of risk
- An elevated baseline tryptase level may be a significant risk factor for repeated severe reactions to Hymenoptera insect stings and drugs, in conjunction with other clinical findings.2,4,5
Relevant treatment decisions
- Help decide if VIT is appropriate for patients with previous reactions to bee and/or wasp stings.2,4,5
- Decide on lifelong treatment for venom allergic patients with underlying mastocytosis.2,4,5
- Schwartz, L.B., Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am, 2006. 26(3): p. 451-63.
- Bonifazi, F., et al., Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy, 2005. 60(12): p. 1459-70.
- Horny H-P et al. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (Eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edition). IARC: Lyon, 2017. .
- Simons, F.E., et al., International consensus on (ICON) anaphylaxis. World Allergy Organ J, 2014. 7(1): p. 9.
- Simons, F.E., et al., 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J, 2015. 8(1): p. 32.
